Hedge Fund - Vivo Capital
Terns Pharmaceuticals Inc. (TERN)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q4 (2025-12-31) | $216,015,891 | 13.96% | 5,346,928 | $23.11 |
| 2 | 2025 - Q3 (2025-09-30) | $51,787,052 | 4.17% | 6,895,746 | $6.39 |
| 3 | 2025 - Q2 (2025-06-30) | $25,721,133 | 2.63% | 6,895,746 | $3.12 |
| 4 | 2025 - Q1 (2025-03-31) | $19,032,259 | 2.52% | 6,895,746 | $4.08 |
| 5 | 2024 - Q4 (2024-12-31) | $38,202,433 | 4.27% | 6,895,746 | $6.77 |
| 6 | 2024 - Q3 (2024-09-30) | $57,510,522 | 4.75% | 6,895,746 | $8.23 |
| 7 | 2024 - Q2 (2024-06-30) | $42,106,176 | 3.88% | 6,182,992 | $6.06 |
| 8 | 2024 - Q1 (2024-03-31) | $43,676,428 | 3.43% | 6,657,992 | $6.53 |
| 9 | 2023 - Q4 (2023-12-31) | $43,210,368 | 3.53% | 6,657,992 | $5.29 |
| 10 | 2023 - Q3 (2023-09-30) | $33,489,700 | 3.66% | 6,657,992 | $6.35 |
| 11 | 2023 - Q2 (2023-06-30) | $58,257,430 | 4.02% | 6,657,992 | $11.66 |
| 12 | 2023 - Q1 (2023-03-31) | $78,830,625 | 5.47% | 6,657,992 | $9.56 |
| 13 | 2022 - Q4 (2022-12-31) | $67,778 | 7.8% | 6,657,992 | $6.66 |
| 14 | 2022 - Q3 (2022-09-30) | $34,747,000 | 3.83% | 5,899,372 | $3.72 |
| 15 | 2022 - Q2 (2022-06-30) | $6,634,000 | 0.66% | 2,675,133 | $2.00 |
| 16 | 2022 - Q1 (2022-03-31) | $7,945,000 | 0.54% | 2,675,133 | $4.27 |
| 17 | 2021 - Q4 (2021-12-31) | $18,913,000 | 1.14% | 2,675,133 | $8.33 |
| 18 | 2021 - Q3 (2021-09-30) | $27,875,000 | 1.25% | 2,675,133 | $10.37 |
| 19 | 2021 - Q2 (2021-06-30) | $32,797,000 | 1.41% | 2,675,133 | $17.03 |
| 20 | 2021 - Q1 (2021-03-31) | $58,853,000 | 2.06% | 2,675,133 | $21.92 |
The displayed share prices are average quarterly stock market prices.
Hedge Fund Resource Center